Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 13
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4037)
- Volume 19, 2023 (180)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 13, 2017
Delirium in hemodialysis predicts mortality: a single-center, long-term observational study
Yasui-Furukori N, Tarakita N, Uematsu W, Saito H, Nakamura K, Ohyama C, Sugawara N
Neuropsychiatric Disease and Treatment 2017, 13:3011-3016
Published Date: 14 December 2017
Accurately identifying patients who are excellent candidates or unsuitable for a medication: a novel approach
South C, Rush AJ, Carmody TJ, Jha MK, Trivedi MH
Neuropsychiatric Disease and Treatment 2017, 13:3001-3010
Published Date: 15 December 2017
The Walsh Family Resilience Questionnaire: the Italian version
Rocchi S, Ghidelli C, Burro R, Vitacca M, Scalvini S, Della Vedova AM, Roselli G, Ramponi JP, Bertolotti G
Neuropsychiatric Disease and Treatment 2017, 13:2987-2999
Published Date: 14 December 2017
Differences between autogenous and reactive obsessions in terms of metacognitions and automatic thoughts
Keles Altun İ, Uysal E, Özkorumak Karagüzel E
Neuropsychiatric Disease and Treatment 2017, 13:2977-2985
Published Date: 12 December 2017
Altered emotional prosody processing in patients with Parkinson’s disease after subthalamic nucleus stimulation
Jin Y, Mao Z, Ling Z, Xu X, Xie G, Yu X
Neuropsychiatric Disease and Treatment 2017, 13:2965-2975
Published Date: 11 December 2017
Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder
Citrome L, Landbloom R, Chang C, Earley W
Neuropsychiatric Disease and Treatment 2017, 13:2955-2963
Published Date: 11 December 2017
Verbal memory improvement in first-episode psychosis APOE-ε4 carriers: a pleiotropic effect?
Vila-Rodriguez F, Lang DJ, Baitz H, Gicas K, Thornton AE, Ehmann TS, Smith GN, Barr AM, Torres IJ, Kopala LC, MacEwan GW, Müller DJ, Kennedy JL, Honer WG
Neuropsychiatric Disease and Treatment 2017, 13:2945-2953
Published Date: 8 December 2017
Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia
Han JY, Li Y, Wang XM
Neuropsychiatric Disease and Treatment 2017, 13:2935-2943
Published Date: 5 December 2017
Screening for mild cognitive impairment in patients with cardiovascular risk factors
Yaneva-Sirakova T, Traykov L, Petrova J, Gruev I, Vassilev D
Neuropsychiatric Disease and Treatment 2017, 13:2925-2934
Published Date: 5 December 2017
Effect of handedness on auditory attentional performance in ADHD students
Schmidt SL, Carvaho AL, Simoes EN
Neuropsychiatric Disease and Treatment 2017, 13:2921-2924
Published Date: 1 December 2017
The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
McIntyre RS
Neuropsychiatric Disease and Treatment 2017, 13:2913-2919
Published Date: 29 November 2017
Cytokines and depression in cancer patients and caregivers
Li M, Kouzmina E, McCusker M, Rodin D, Boutros PC, Paige CJ, Rodin G
Neuropsychiatric Disease and Treatment 2017, 13:2903-2911
Published Date: 28 November 2017
Altered emotional recognition and expression in patients with Parkinson’s disease
Jin Y, Mao Z, Ling Z, Xu X, Zhang Z, Yu X
Neuropsychiatric Disease and Treatment 2017, 13:2891-2902
Published Date: 27 November 2017
Korsakoff’s syndrome: a critical review
Arts NJM, Walvoort SJW, Kessels RPC
Neuropsychiatric Disease and Treatment 2017, 13:2875-2890
Published Date: 27 November 2017
The effect of errorless learning on quality of life in patients with Korsakoff’s syndrome
Rensen YCM, Egger JIM, Westhoff J, Walvoort SJW, Kessels RPC
Neuropsychiatric Disease and Treatment 2017, 13:2867-2873
Published Date: 27 November 2017
No association between dopamine D3 receptor gene Ser9Gly polymorphism (rs6280) and risk of schizophrenia: an updated meta-analysis
Qi XL, Xuan JF, Xing JX, Wang BJ, Yao J
Neuropsychiatric Disease and Treatment 2017, 13:2855-2865
Published Date: 23 November 2017
Abnormal regional spontaneous neural activity in visual pathway in retinal detachment patients: a resting-state functional MRI study
Huang X, Li D, Li H, Zhong Y, Freeberg S, Bao J, Zeng X, Shao Y
Neuropsychiatric Disease and Treatment 2017, 13:2849-2854
Published Date: 22 November 2017
Group cognitive–behavioral therapy in insomnia: a cross-sectional case-controlled study
Mao H, Ji Y, Xu Y, Tang G, Yu Z, Xu L, Shen C, Wang W
Neuropsychiatric Disease and Treatment 2017, 13:2841-2848
Published Date: 21 November 2017
Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report
Okazaki K, Yamamuro K, Kishimoto T
Neuropsychiatric Disease and Treatment 2017, 13:2837-2840
Published Date: 21 November 2017
Altered microstructure of brain white matter in females with anorexia nervosa: a diffusion tensor imaging study
Hu SH, Feng H, Xu TT, Zhang HR, Zhao ZY, Lai JB, Xu DR, Xu Y
Neuropsychiatric Disease and Treatment 2017, 13:2829-2836
Published Date: 21 November 2017
The efficacy of antipsychotics for prolonged delirium with renal dysfunction
Asano S, Kunii Y, Hoshino H, Osakabe Y, Shiga T, Itagaki S, Miura I, Yabe H
Neuropsychiatric Disease and Treatment 2017, 13:2823-2828
Published Date: 16 November 2017
Immigration-related mental health disorders in refugees 5–18 years old living in Turkey
Yalın Sapmaz Ş, Uzel Tanrıverdi B, Öztürk M, Gözaçanlar Ö, Yörük Ülker G, Özkan Y
Neuropsychiatric Disease and Treatment 2017, 13:2813-2821
Published Date: 10 November 2017
Depression, anxiety, stress, and their associated factors among Jimma University staff, Jimma, Southwest Ethiopia, 2016: a cross-sectional study
Yeshaw Y, Mossie A
Neuropsychiatric Disease and Treatment 2017, 13:2803-2812
Published Date: 8 November 2017
Efficacy and safety of DFN-15, an oral liquid formulation of celecoxib, in adults with migraine: a multicenter, randomized, placebo-controlled, double-blind, crossover study
Munjal S, Bennett A
Neuropsychiatric Disease and Treatment 2017, 13:2797-2802
Published Date: 7 November 2017
A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
Zhong Z, Wang L, Wen X, Liu Y, Fan Y, Liu Z
Neuropsychiatric Disease and Treatment 2017, 13:2781-2796
Published Date: 7 November 2017
Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
Brasso C, Bellino S, Bozzatello P, Montemagni C, Rocca P
Neuropsychiatric Disease and Treatment 2017, 13:2767-2779
Published Date: 7 November 2017
Transplantation of bone mesenchymal stem cells promotes angiogenesis and improves neurological function after traumatic brain injury in mouse
Guo SW, Zhen YW, Wang AR
Neuropsychiatric Disease and Treatment 2017, 13:2757-2765
Published Date: 6 November 2017
Post-marketing observational program of the effectiveness of fluvoxamine for the treatment of depression in patients with neurological disorders: the FRIENDS study
Yahno NN, Fedotova AV
Neuropsychiatric Disease and Treatment 2017, 13:2747-2756
Published Date: 2 November 2017
Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015
Blozik E, Rapold R, Eichler K, Reich O
Neuropsychiatric Disease and Treatment 2017, 13:2737-2745
Published Date: 1 November 2017
Resveratrol ameliorates chronic unpredictable mild stress-induced depression-like behavior: involvement of the HPA axis, inflammatory markers, BDNF, and Wnt/β-catenin pathway in rats
Yang X, Song S, Xu Y
Neuropsychiatric Disease and Treatment 2017, 13:2727-2736
Published Date: 27 October 2017
Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease
Murakami H, Nohara T, Shozawa H, Owan Y, Kuroda T, Yano S, Kezuka M, Kawamura M, Ono K
Neuropsychiatric Disease and Treatment 2017, 13:2719-2726
Published Date: 25 October 2017
Effects of short-term piano training on measures of finger tapping, somatosensory perception and motor-related brain activity in patients with cerebral palsy
Alves-Pinto A, Ehrlich S, Cheng G, Turova V, Blumenstein T, Lampe R
Neuropsychiatric Disease and Treatment 2017, 13:2705-2718
Published Date: 25 October 2017
Transient global amnesia: current perspectives
Spiegel DR, Smith J, Wade RR, Cherukuru N, Ursani A, Dobruskina Y, Crist T, Busch RF, Dhanani RM, Dreyer N
Neuropsychiatric Disease and Treatment 2017, 13:2691-2703
Published Date: 24 October 2017
Psychosocial intervention for patients with type 2 diabetes mellitus and comorbid depression: a meta-analysis of randomized controlled trials
Xie J, Deng W
Neuropsychiatric Disease and Treatment 2017, 13:2681-2690
Published Date: 24 October 2017
Comparison of spontaneous brain activity revealed by regional homogeneity in AQP4-IgG neuromyelitis optica-optic neuritis versus MOG-IgG optic neuritis patients: a resting-state functional MRI study
Wang J, Tian Y, Shao Y, Feng H, Qin L, Xu W, Liu H, Xu Q, Wei S, Ma L
Neuropsychiatric Disease and Treatment 2017, 13:2669-2679
Published Date: 24 October 2017
Association of TNF-alpha G-308A gene polymorphism with depression: a meta-analysis
Shin KH, Jeong HC, Choi DH, Kim SN, Kim TE
Neuropsychiatric Disease and Treatment 2017, 13:2661-2668
Published Date: 20 October 2017
Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations
Han J, Yang M, Zhu J, Jin T
Neuropsychiatric Disease and Treatment 2017, 13:2653-2660
Published Date: 20 October 2017
A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness
Kopelowicz A, Baker RA, Zhao C, Brewer C, Lawson E, Peters-Strickland T
Neuropsychiatric Disease and Treatment 2017, 13:2641-2651
Published Date: 19 October 2017
Bupropion interferes with the image diagnosis of Parkinson's disease
Lin CH, Lane HY
Neuropsychiatric Disease and Treatment 2017, 13:2637-2639
Published Date: 19 October 2017
Identification of a novel CACNA1A mutation in a Chinese family with autosomal recessive progressive myoclonic epilepsy
Lv YD, Wang Z, Liu C, Cui L
Neuropsychiatric Disease and Treatment 2017, 13:2631-2636
Published Date: 19 October 2017
Differences in serum zinc levels in acutely ill and remitted adolescents and young adults with bulimia nervosa in comparison with healthy controls – a cross-sectional pilot study
Zepf FD, Rao P, Runions K, Stewart RM, Moore JK, Wong JWY, Linden M, Sungurtekin I, Glass F, Gut L, Peetz D, Hintereder G, Schaab M, Poustka F, Wöckel L
Neuropsychiatric Disease and Treatment 2017, 13:2621-2630
Published Date: 17 October 2017
Thalamo–cortical network underlying deep brain stimulation of centromedian thalamic nuclei in intractable epilepsy: a multimodal imaging analysis
Kim SH, Lim SC, Yang DW, Cho JH, Son BC, Kim J, Hong SB, Shon YM
Neuropsychiatric Disease and Treatment 2017, 13:2607-2619
Published Date: 17 October 2017
Coping, schemas, and cardiovascular risks – study protocol
Slepecky M, Kotianova A, Prasko J, Majercak I, Gyorgyova E, Kotian M, Zatkova M, Tonhajzerova I, Chupacova M, Popelkova M
Neuropsychiatric Disease and Treatment 2017, 13:2599-2605
Published Date: 13 October 2017
Abnormal functional connectivity of the posterior cingulate cortex is associated with depressive symptoms in patients with Alzheimer’s disease
Zhang J, Guo Z, Liu X, Jia X, Li J, Li Y, Lv D, Chen W
Neuropsychiatric Disease and Treatment 2017, 13:2589-2598
Published Date: 11 October 2017
Relationship of negative and positive core beliefs about the self with dysfunctional attitudes in three aspects of life
Otani K, Suzuki A, Matsumoto Y, Shirata T
Neuropsychiatric Disease and Treatment 2017, 13:2585-2588
Published Date: 12 October 2017
Sporadic hyperekplexia due to self-limiting brainstem encephalopathy
Yilmaz D, Cengiz B
Neuropsychiatric Disease and Treatment 2017, 13:2581-2584
Published Date: 9 October 2017
Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders
Finsterer J, Zarrouk-Mahjoub S
Neuropsychiatric Disease and Treatment 2017, 13:2569-2579
Published Date: 6 October 2017
Interpersonal sensitivity mediates the effects of child abuse and affective temperaments on depressive symptoms in the general adult population
Otsuka A, Takaesu Y, Sato M, Masuya J, Ichiki M, Kusumi I, Inoue T
Neuropsychiatric Disease and Treatment 2017, 13:2559-2568
Published Date: 5 October 2017
MLC601 in vascular dementia: an efficacy and safety pilot study
Pakdaman H, Amini Harandi A, Gharagozli K, Abbasi M, Ghaffarpour M, Ashrafi F, Delavar Kasmaei H, Amini Harandi A
Neuropsychiatric Disease and Treatment 2017, 13:2551-2557
Published Date: 5 October 2017
19q12q13.2 duplication syndrome: neuropsychiatric long-term follow-up of a new case and literature update
Nacinovich R, Villa N, Broggi F, Tavaniello C, Bomba M, Conconi D, Redaelli S, Sala E, Lavitrano M, Neri F
Neuropsychiatric Disease and Treatment 2017, 13:2545-2550
Published Date: 4 October 2017
Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials
Cheng YS, Tseng PT, Chen YW, Stubbs B, Yang WC, Chen TY, Wu CK, Lin PY
Neuropsychiatric Disease and Treatment 2017, 13:2531-2543
Published Date: 4 October 2017
Letter to the editor regarding the article “The use of Psychiatric Electroencephalography Evaluations Registry (PEER) to personalize pharmacotherapy”
Weina PJ, Brooks S
Neuropsychiatric Disease and Treatment 2017, 13:2527-2530
Published Date: 4 October 2017
Children with borderline intellectual functioning and autism spectrum disorder: developmental trajectories from 4 to 11 years of age
Barnevik Olsson M, Holm A, Westerlund J, Lundholm Hedvall Å, Gillberg C, Fernell E
Neuropsychiatric Disease and Treatment 2017, 13:2519-2526
Published Date: 4 October 2017
Frequencies of circulating B- and T-lymphocytes as indicators for stroke outcomes
Wang Y, Liu J, Wang X, Liu Z, Li F, Chen F, Geng X, Ji Z, Du H, Hu X
Neuropsychiatric Disease and Treatment 2017, 13:2509-2518
Published Date: 3 October 2017
Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
Haider M, Shafqat MN
Neuropsychiatric Disease and Treatment 2017, 13:2505-2508
Published Date: 3 October 2017
Motivation to change and posttreatment temptation to drink: a multicenter study among alcohol-dependent patients
Fiabane E, Ottonello M, Zavan V, Pistarini C, Giorgi I
Neuropsychiatric Disease and Treatment 2017, 13:2497-2504
Published Date: 3 October 2017
Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study
Kitahata R, Nakajima S, Uchida H, Hayashida T, Takahashi M, Nio S, Hirano J, Nagaoka M, Suzuki T, Jinno H, Kitagawa Y, Mimura M
Neuropsychiatric Disease and Treatment 2017, 13:2489-2496
Published Date: 3 October 2017
Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides
Li Y, Su R, Xu S, Huang Q, Xu H
Neuropsychiatric Disease and Treatment 2017, 13:2477-2487
Published Date: 27 September 2017
Laser interstitial thermal therapy for the treatment of epilepsy: evidence to date
Shukla ND, Ho AL, Pendharkar AV, Sussman ES, Halpern CH
Neuropsychiatric Disease and Treatment 2017, 13:2469-2475
Published Date: 26 September 2017
Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine
Tokuoka H, Nishihara M, Fujikoshi S, Yoshikawa A, Kuga A
Neuropsychiatric Disease and Treatment 2017, 13:2457-2467
Published Date: 25 September 2017
Atypical depression: current perspectives
Łojko D, Rybakowski JK
Neuropsychiatric Disease and Treatment 2017, 13:2447-2456
Published Date: 20 September 2017
Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study
Harada E, Satoi Y, Kuga A, Tokuoka H, Kikuchi T, Watanabe K, Alev L, Mimura M
Neuropsychiatric Disease and Treatment 2017, 13:2437-2445
Published Date: 19 September 2017
Factors associated with bullying victimization among Korean adolescents
Seo HJ, Jung YE, Kim MD, Bahk WM
Neuropsychiatric Disease and Treatment 2017, 13:2429-2435
Published Date: 18 September 2017
The comorbidity of bipolar disorder, diabetes mellitus, and autoimmune hypothyroidism in an adult woman with Turner’s syndrome: a case report
Li J, Hong X, Xu H
Neuropsychiatric Disease and Treatment 2017, 13:2425-2428
Published Date: 18 September 2017
Need for medication to complement catecholamines in smoking cessation of hardcore smokers
Kawai A, Kurita M, Nishino S, Hirata E, Sato T, Okubo Y
Neuropsychiatric Disease and Treatment 2017, 13:2419-2424
Published Date: 18 September 2017
Medical comorbidities in patients with serious mental illness: a retrospective study of mental health patients attending an outpatient clinic in Qatar
Zolezzi M, Abdulrhim S, Isleem N, Zahrah F, Eltorki Y
Neuropsychiatric Disease and Treatment 2017, 13:2411-2418
Published Date: 15 September 2017
Sex differences in obesity and cognitive function in a cognitively normal aging Chinese Han population
Li W, Qiu Q, Sun L, Yue L, Wang T, Li X, Xiao S
Neuropsychiatric Disease and Treatment 2017, 13:2405-2410
Published Date: 14 September 2017
Biochemical assessments of thyroid profile, serum 25-hydroxycholecalciferol and cluster of differentiation 5 expression levels among children with autism
Desoky T, Hassan MH, Fayed HM, Sakhr HM
Neuropsychiatric Disease and Treatment 2017, 13:2397-2403
Published Date: 14 September 2017
Depression and family support in breast cancer patients
Su JA, Yeh DC, Chang CC, Lin TC, Lai CH, Hu PY, Ho YF, Chen VC, Wang TN, Gossop M
Neuropsychiatric Disease and Treatment 2017, 13:2389-2396
Published Date: 13 September 2017
Triadic interactions in families with preterm children: a comparative study with children born at term
Gatta M, Miscioscia M, Svanellini L, Brianda ME, Guerra G, Battistella PA, Simonelli A
Neuropsychiatric Disease and Treatment 2017, 13:2375-2388
Published Date: 13 September 2017
Application of a stratum-specific likelihood ratio analysis in a screen for depression among a community-dwelling population in Japan
Sugawara N, Kaneda A, Takahashi I, Nakaji S, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2017, 13:2369-2374
Published Date: 12 September 2017
Low uric acid is a risk factor in mild cognitive impairment
Xue L, Liu Y, Xue H, Xue J, Sun K, Wu L, Hou P
Neuropsychiatric Disease and Treatment 2017, 13:2363-2367
Published Date: 11 September 2017
Natural reduced water suppressed anxiety and protected the heightened oxidative stress in rats
Masuda K, Tanaka Y, Kanehisa M, Ninomiya T, Inoue A, Higuma H, Kawashima C, Nakanishi M, Okamoto K, Akiyoshi J
Neuropsychiatric Disease and Treatment 2017, 13:2357-2362
Published Date: 8 September 2017
Ictal heart rate changes and the effects of vagus nerve stimulation for patients with refractory epilepsy
Chen W, Meng FG
Neuropsychiatric Disease and Treatment 2017, 13:2351-2356
Published Date: 5 September 2017
Relationship between subtypes and symptoms of ADHD, insomnia, and nightmares in connection with quality of life in children
Grünwald J, Schlarb AA
Neuropsychiatric Disease and Treatment 2017, 13:2341-2350
Published Date: 5 September 2017
Cognitive behavioral therapy for somatic symptom disorders in later life: a prospective comparative explorative pilot study in two clinical populations
Verdurmen MJH, Videler AC, Kamperman AM, Khasho D, van der Feltz-Cornelis CM
Neuropsychiatric Disease and Treatment 2017, 13:2331-2339
Published Date: 1 September 2017
Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?
Hu JB, Lai JB, Hu SH, Xu Y
Neuropsychiatric Disease and Treatment 2017, 13:2327-2330
Published Date: 31 August 2017
Levetiracetam is associated with decrease in subclinical epileptiform discharges and improved cognitive functions in pediatric patients with autism spectrum disorder
Wang MJ, Jiang L, Tang XJ
Neuropsychiatric Disease and Treatment 2017, 13:2321-2326
Published Date: 31 August 2017
Sociodemographic variables and social values: relationship with work-attendance problems in Brunei public- and private-sector employees
Mundia L, Mahalle S, Matzin R, Zakaria GAN, Abdullah NZM
Neuropsychiatric Disease and Treatment 2017, 13:2307-2319
Published Date: 31 August 2017
Risk of post-traumatic epilepsy after severe head injury in patients with at least one seizure
Chen W, Li MD, Wang GF, Yang XF, Liu L, Meng FG
Neuropsychiatric Disease and Treatment 2017, 13:2301-2306
Published Date: 30 August 2017
Effects of bromadiolone poisoning on the central nervous system
Wang M, Yang Y, Hou Y, Ma W, Jia R, Chen J
Neuropsychiatric Disease and Treatment 2017, 13:2297-2300
Published Date: 30 August 2017
Attitudes toward antipsychotic treatment among patients with bipolar disorders and their clinicians: a systematic review
Sajatovic M, DiBiasi F, Legacy SN
Neuropsychiatric Disease and Treatment 2017, 13:2285-2296
Published Date: 30 August 2017
Association of interleukin-33 gene polymorphisms with susceptibility to late onset Alzheimer’s disease: a meta-analysis
Zhong X, Liu M, He M, Du K, Wei M
Neuropsychiatric Disease and Treatment 2017, 13:2275-2284
Published Date: 30 August 2017
A case of schizophrenia comorbid for tetralogy of Fallot treated with clozapine: further considerations on a role for 22q.11.2 in the proneness for seizures
Kashiwagi H, Ikezawa S, Sumiyoshi T, Kadono A, Segawa K, Takeda K, Omori M, Taguchi H, Hirabayashi N
Neuropsychiatric Disease and Treatment 2017, 13:2271-2273
Published Date: 29 August 2017
Once-monthly paliperidone palmitate in early stage schizophrenia – a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia
Emsley R, Hargarter L, Bergmans P, Uglešić B, Sengül AC, Petralia A, Khannanova A, Cherubin P, Schreiner A
Neuropsychiatric Disease and Treatment 2017, 13:2261-2269
Published Date: 29 August 2017
Reversible global aphasia as a side effect of quetiapine: a case report and literature review
Chien CF, Huang P, Hsieh SW
Neuropsychiatric Disease and Treatment 2017, 13:2257-2260
Published Date: 28 August 2017
Early predictors of brain damage in full-term newborns with hypoxic ischemic encephalopathy [Corrigendum]
Alkholy UM, Abdalmonem N, Zaki A, Ali YF, Mohamed SA, Abdelsalam NI, Abu Hashim MI, Abou Sekkien M, Elsherbiny YM
Neuropsychiatric Disease and Treatment 2017, 13:2255-2256
Published Date: 26 August 2017
Fan the flame: trazodone-induced mania in a unipolar depressed patient with stable sertraline treatment
Hu JB, Lai JB, Zheng HZ, Hu SH, Xu Y
Neuropsychiatric Disease and Treatment 2017, 13:2251-2254
Published Date: 24 August 2017
Analyzing a single nucleotide polymorphism in schizophrenia: a meta-analysis approach
Falola O, Osamor VC, Adebiyi M, Adebiyi E
Neuropsychiatric Disease and Treatment 2017, 13:2243-2250
Published Date: 23 August 2017
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
Dayabandara M, Hanwella R, Ratnatunga S, Seneviratne S, Suraweera C, de Silva VA
Neuropsychiatric Disease and Treatment 2017, 13:2231-2241
Published Date: 22 August 2017
Association between COMT Val158Met and DAT1 polymorphisms and depressive symptoms in the obese population
Bieliński M, Jaracz M, Lesiewska N, Tomaszewska M, Sikora M, Junik R, Kamińska A, Tretyn A, Borkowska A
Neuropsychiatric Disease and Treatment 2017, 13:2221-2229
Published Date: 18 August 2017
Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]
Terao T, Ishida A, Kimura T, Yoshida M, Hara T
Neuropsychiatric Disease and Treatment 2017, 13:2219-2220
Published Date: 18 August 2017
Improvements in motor tasks through the use of smartphone technology for individuals with Duchenne muscular dystrophy
Capelini CM, Silva TD, Tonks J, Watson S, Alvarez MPB, Menezes LDC, Favero FM, Caromano FA, Massetti T, de Mello Monteiro CB
Neuropsychiatric Disease and Treatment 2017, 13:2209-2217
Published Date: 18 August 2017
Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study
Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Mathews M, Feng Y, Yu L, Takahashi M, Liu D, Wang G, Yoon J, Chen JJ
Neuropsychiatric Disease and Treatment 2017, 13:2193-2207
Published Date: 17 August 2017
Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study
Okuda T, Asano K, Numata N, Hirano Y, Yamamoto T, Tanaka M, Matsuzawa D, Shimizu E, Iyo M, Nakazato M
Neuropsychiatric Disease and Treatment 2017, 13:2185-2191
Published Date: 16 August 2017
A case of paroxysmal kinesigenic dyskinesia which exhibited the phenotype of anxiety disorder
Kunii Y, Matsuda N, Yabe H
Neuropsychiatric Disease and Treatment 2017, 13:2181-2184
Published Date: 16 August 2017
Bipolar II disorder as the initial presentation of CADASIL: an underdiagnosed manifestation
Wang J, Li J, Kong F, Lv H, Guo Z
Neuropsychiatric Disease and Treatment 2017, 13:2175-2179
Published Date: 14 August 2017
Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?
Porfirio MC, Gomes de Almeida JP, Stornelli M, Giovinazzo S, Purper-Ouakil D, Masi G
Neuropsychiatric Disease and Treatment 2017, 13:2167-2174
Published Date: 10 August 2017
Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
Saragoussi D, Touya M, Haro JM, Jönsson B, Knapp M, Botrel B, Florea I, Loft H, Rive B
Neuropsychiatric Disease and Treatment 2017, 13:2151-2165
Published Date: 9 August 2017
Moderating role of self-efficacy on the associations of social support with depressive and anxiety symptoms in Chinese patients with rheumatoid arthritis
Liu L, Xu N, Wang L
Neuropsychiatric Disease and Treatment 2017, 13:2141-2150
Published Date: 9 August 2017
Early predictors of brain damage in full-term newborns with hypoxic ischemic encephalopathy
Alkholy UM, Abdalmonem N, Zaki A, Ali YF, Mohamed SA, Abdelsalam NI, Abu Hashim MI, Abou Sekkien M, Elsherbiny YM
Neuropsychiatric Disease and Treatment 2017, 13:2133-2139
Published Date: 8 August 2017
Factors associated with depressive symptoms in people living with HIV attending antiretroviral clinic at Fitche Zonal Hospital, Central Ethiopia: cross-sectional study conducted in 2012
Yeneabat T, Bedaso A, Amare T
Neuropsychiatric Disease and Treatment 2017, 13:2125-2131
Published Date: 8 August 2017
An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
Kuga A, Tsuji T, Hayashi S, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T
Neuropsychiatric Disease and Treatment 2017, 13:2115-2124
Published Date: 4 August 2017
An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
Kuga A, Tsuji T, Hayashi S, Matsubara M, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T
Neuropsychiatric Disease and Treatment 2017, 13:2105-2114
Published Date: 4 August 2017
Which psychological, psychophysiological, and anthropometric factors are connected with life events, depression, and quality of life in patients with cardiovascular disease
Slepecky M, Kotianova A, Prasko J, Majercak I, Gyorgyova E, Kotian M, Zatkova M, Popelkova M, Ociskova M, Tonhajzerova I
Neuropsychiatric Disease and Treatment 2017, 13:2093-2104
Published Date: 4 August 2017
Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein–Barr virus infection in adults
Guo YJ, Wang SH, Jiang B, Li JL, Liu L, Wang J, Zhao WQ, Jia J
Neuropsychiatric Disease and Treatment 2017, 13:2085-2092
Published Date: 3 August 2017
Comorbidity of schizophrenia and social phobia – impact on quality of life, hope, and personality traits: a cross sectional study
Vrbova K, Prasko J, Ociskova M, Holubova M
Neuropsychiatric Disease and Treatment 2017, 13:2073-2083
Published Date: 3 August 2017
Suicidal and homicidal tendencies after Lyme disease: an ignored problem
Munir A, Aadil M, Rehan Khan A
Neuropsychiatric Disease and Treatment 2017, 13:2069-2071
Published Date: 2 August 2017
La belle indifférence revisited: a case report on progressive supranuclear palsy misdiagnosed as conversion disorder
van Meerkerk-Aanen PJ, de Vroege L, Khasho D, Foruz A, van Asseldonk JT, van der Feltz-Cornelis CM
Neuropsychiatric Disease and Treatment 2017, 13:2057-2067
Published Date: 2 August 2017
Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study
Zhao JP, Li LH, Shi JG, Li Y, Xu XF, Li KQ, Zhang LL, Cai SL, Feng Y, Zhuo JM, Liu WH, Lu HF
Neuropsychiatric Disease and Treatment 2017, 13:2045-2056
Published Date: 2 August 2017
MicroRNA expression profiles in chronic epilepsy rats and neuroprotection from seizures by targeting miR-344a
Liu XX, Liao YH, Wang XX, Zou DH, Luo C, Jian CD, Wu Y
Neuropsychiatric Disease and Treatment 2017, 13:2037-2044
Published Date: 31 July 2017
Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study
Durgam S, Landbloom RP, Mackle M, Wu X, Mathews M, Nasrallah HA
Neuropsychiatric Disease and Treatment 2017, 13:2021-2035
Published Date: 31 July 2017
Abnormal intrinsic functional hubs in alcohol dependence: evidence from a voxelwise degree centrality analysis
Luo X, Guo LH, Dai XJ, Wang Q, Zhu W, Miao X, Gong H
Neuropsychiatric Disease and Treatment 2017, 13:2011-2020
Published Date: 28 July 2017
Electrophysiological findings of Turkish patients with restless legs syndrome
Özsimsek A, Koyuncuoglu HR
Neuropsychiatric Disease and Treatment 2017, 13:2005-2010
Published Date: 27 July 2017
Involvement of up-regulation of miR-210 in a rat epilepsy model [Corrigendum]
Chen L, Zheng H, Zhang S
Neuropsychiatric Disease and Treatment 2017, 13:2003-2004
Published Date: 26 July 2017
Sleep problems in university students – an intervention
Schlarb AA, Friedrich A, Claßen M
Neuropsychiatric Disease and Treatment 2017, 13:1989-2001
Published Date: 26 July 2017
The economic burden of schizophrenia in Malaysia
Teoh SL, Chong HY, Abdul Aziz S, Chemi N, Othman AR, Md Zaki N, Vanichkulpitak P, Chaiyakunapruk N
Neuropsychiatric Disease and Treatment 2017, 13:1979-1987
Published Date: 28 July 2017
Risperidone-induced reversible neutropenia
Kattalai Kailasam V, Chima V, Nnamdi U, Sharma K, Shah K
Neuropsychiatric Disease and Treatment 2017, 13:1975-1977
Published Date: 25 July 2017
Modeling association between times to recurrence of the different polarities in bipolar disorder among service seekers in urban Nigeria: a survival analysis approach
Fagbamigbe AF, Makanjuola VA
Neuropsychiatric Disease and Treatment 2017, 13:1967-1974
Published Date: 21 July 2017
Spontaneous alterations of regional brain activity in patients with adult generalized anxiety disorder
Xia L, Li S, Wang T, Guo Y, Meng L, Feng Y, Cui Y, Wang F, Ma J, Jiang G
Neuropsychiatric Disease and Treatment 2017, 13:1957-1965
Published Date: 20 July 2017
SoCIAL – training cognition in schizophrenia: a pilot study
Palumbo D, Mucci A, Piegari G, D'Alise V, Mazza A, Galderisi S
Neuropsychiatric Disease and Treatment 2017, 13:1947-1956
Published Date: 20 July 2017
The regional neuronal activity in left posterior middle temporal gyrus is correlated with the severity of chronic aphasia
Li J, Du D, Gao W, Sun X, Xie H, Zhang G, Li J, Li H, Li K
Neuropsychiatric Disease and Treatment 2017, 13:1937-1945
Published Date: 20 July 2017
Impact of help-seeking behavior and partner support on postpartum depression among Saudi women
Almutairi AF, Salam M, Alanazi S, Alweldawi M, Alsomali N, Alotaibi N
Neuropsychiatric Disease and Treatment 2017, 13:1929-1936
Published Date: 20 July 2017
The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
Kishi T, Matsunaga S, Iwata N
Neuropsychiatric Disease and Treatment 2017, 13:1909-1928
Published Date: 20 July 2017
Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder
Lai J, Lu Q, Huang T, Hu S, Xu Y
Neuropsychiatric Disease and Treatment 2017, 13:1905-1908
Published Date: 19 July 2017
Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study
Hamdy SM, Abdel-Naseer M, Shalaby NM, Elmazny AN, Nemr AA, Hassan A, Hegazy MI, Mourad HS, Kishk NA, Nada MA, Abdelalim A, Fouad AM, Shehata HS
Neuropsychiatric Disease and Treatment 2017, 13:1895-1903
Published Date: 18 July 2017
Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions. A randomized controlled trial in the general hospital setting (CC-DIM)
Goorden M, van der Feltz-Cornelis CM, van Steenbergen-Weijenburg KM, Horn EK, Beekman ATF, Hakkaart-van Roijen L
Neuropsychiatric Disease and Treatment 2017, 13:1881-1893
Published Date: 18 July 2017
Prevalence, symptomatic features, and factors associated with sleep disturbance/insomnia in Japanese patients with type-2 diabetes
Narisawa H, Komada Y, Miwa T, Shikuma J, Sakurai M, Odawara M, Inoue Y
Neuropsychiatric Disease and Treatment 2017, 13:1873-1880
Published Date: 18 July 2017
Excoriation (skin-picking) disorder: a systematic review of treatment options
Lochner C, Roos A, Stein DJ
Neuropsychiatric Disease and Treatment 2017, 13:1867-1872
Published Date: 14 July 2017
Depression in blepharospasm: a question of facial feedback?
Bedarf JR, Kebir S, Michelis JP, Wabbels B, Paus S
Neuropsychiatric Disease and Treatment 2017, 13:1861-1865
Published Date: 14 July 2017
Genetic and epigenetic mechanisms of epilepsy: a review
Chen T, Giri M, Xia ZY, Subedi YN, Li Y
Neuropsychiatric Disease and Treatment 2017, 13:1841-1859
Published Date: 13 July 2017
Anxiety sensitivity as a predictor of broad dimensions of psychopathology after cognitive behavioral therapy for panic disorder
Ino K, Ogawa S, Kondo M, Imai R, Ii T, Furukawa TA, Akechi T
Neuropsychiatric Disease and Treatment 2017, 13:1835-1840
Published Date: 13 July 2017
Real-time functional magnetic resonance imaging in obsessive-compulsive disorder
Gonçalves ÓF, Batistuzzo MC, Sato JR
Neuropsychiatric Disease and Treatment 2017, 13:1825-1834
Published Date: 12 July 2017
The most important psychological and psychosocial needs of Polish multiple sclerosis patients and their significant others
Potemkowski A, Brola W, Ratajczak A, Ratajczak M, Kowalewski M, Lewita M, Kapica-Topczewska K, Tarasiuk J, Stępień A, Gocyla-Dudar K, Zaborski J, Bartosik-Psujek H
Neuropsychiatric Disease and Treatment 2017, 13:1817-1824
Published Date: 12 July 2017
Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics
McConnell SA, Desai DN, Faldu SP, Hard ML, Wehr AY, Weiden PJ, von Moltke L
Neuropsychiatric Disease and Treatment 2017, 13:1815-1816
Published Date: 12 July 2017
Long noncoding RNA CASC2 predicts the prognosis of glioma patients and functions as a suppressor for gliomas by suppressing Wnt/β-catenin signaling pathway
Wang R, Li Y, Zhu G, Tian B, Zeng W, Yang Y, Li Z
Neuropsychiatric Disease and Treatment 2017, 13:1805-1813
Published Date: 11 July 2017
Sleep disturbances among patients with epilepsy
Staniszewska A, Mąka A, Religioni U, Olejniczak D
Neuropsychiatric Disease and Treatment 2017, 13:1797-1803
Published Date: 10 July 2017
A 6-year follow-up of children assessed for suspected autism spectrum disorder: parents’ experiences of society’s support
Westman Andersson G, Miniscalco C, Gillberg N
Neuropsychiatric Disease and Treatment 2017, 13:1783-1796
Published Date: 7 July 2017
Necrostatin-1 attenuates early brain injury after subarachnoid hemorrhage in rats by inhibiting necroptosis
Chen F, Su X, Lin Z, Lin Y, Yu L, Cai J, Kang D, Hu L
Neuropsychiatric Disease and Treatment 2017, 13:1771-1782
Published Date: 7 July 2017
Attention–memory training yields behavioral and academic improvements in children diagnosed with attention-deficit hyperactivity disorder comorbid with a learning disorder
Farias AC, Cordeiro ML, Felden EPG, Bara TS, Benko CR, Coutinho D, Martins LF, Ferreira RTC, McCracken JT
Neuropsychiatric Disease and Treatment 2017, 13:1761-1769
Published Date: 6 July 2017
Brain regions associated with anosognosia for memory disturbance in Alzheimer’s disease: a magnetic resonance imaging study
Fujimoto H, Matsuoka T, Kato Y, Shibata K, Nakamura K, Yamada K, Narumoto J
Neuropsychiatric Disease and Treatment 2017, 13:1753-1759
Published Date: 5 July 2017
Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
Huss M, Duhan P, Gandhi P, Chen CW, Spannhuth CW, Kumar V
Neuropsychiatric Disease and Treatment 2017, 13:1741-1751
Published Date: 4 July 2017
Neuroprotective effects of curdione against focal cerebral ischemia reperfusion injury in rats
Li XJ, Liang L, Shi HX, Sun XP, Wang J, Zhang LS
Neuropsychiatric Disease and Treatment 2017, 13:1733-1740
Published Date: 30 June 2017
Reduced prefrontal activation during verbal fluency task in chronic insomnia disorder: a multichannel near-infrared spectroscopy study
Sun JJ, Liu XM, Shen CY, Zhang XQ, Sun GX, Feng K, Xu B, Ren XJ, Ma XY, Liu PZ
Neuropsychiatric Disease and Treatment 2017, 13:1723-1731
Published Date: 30 June 2017
Study of the combinatorial impact of empathy and emotion on the processing of conflicts of interest with the event-related potential technique
He XL, Zhang N
Neuropsychiatric Disease and Treatment 2017, 13:1713-1721
Published Date: 29 June 2017
Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study
Liang Y, Yu X
Neuropsychiatric Disease and Treatment 2017, 13:1703-1712
Published Date: 28 June 2017
The use of natalizumab for multiple sclerosis
Brandstadter R, Katz Sand I
Neuropsychiatric Disease and Treatment 2017, 13:1691-1702
Published Date: 28 June 2017
The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature
Nicholson WC, Kempf MC, Moneyham L, Vance DE
Neuropsychiatric Disease and Treatment 2017, 13:1677-1689
Published Date: 28 June 2017
Adapting the short form of the Coping Inventory for Stressful Situations into Chinese
Li C, Liu Q, Hu T, Jin X
Neuropsychiatric Disease and Treatment 2017, 13:1669-1675
Published Date: 27 June 2017
The role of microglia in multiple sclerosis
Luo C, Jian C, Liao Y, Huang Q, Wu Y, Liu X, Zou D, Wu Y
Neuropsychiatric Disease and Treatment 2017, 13:1661-1667
Published Date: 26 June 2017
Brain metabolite values in children with breath-holding spells
Calik M, Sen Dokumaci D, Sarikaya S, Demir M, Isik I, Kazanasmaz H, Kaya C, Kandemir H
Neuropsychiatric Disease and Treatment 2017, 13:1655-1660
Published Date: 26 June 2017
High levels of Nesfatin-1 in relation to the dysfunction of the hypothalamic–pituitary–adrenal and hypothalamus–pituitary–thyroid axes in depressed patients with subclinical hypothyroidism
Xu YY, Liang J, Cao Y, Shan F, Liu Y, Xia QR
Neuropsychiatric Disease and Treatment 2017, 13:1647-1653
Published Date: 23 June 2017
Role of SIRT1/PGC-1α in mitochondrial oxidative stress in autistic spectrum disorder
Bu XS, Wu D, Lu XM, Yang L, Xu XY, Wang J, Tang JL
Neuropsychiatric Disease and Treatment 2017, 13:1633-1645
Published Date: 23 June 2017
Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review
Correia-Melo FS, Argolo FC, Araújo-de-Freitas L, Leal GC, Kapczinski F, Lacerda AL, Quarantini LC
Neuropsychiatric Disease and Treatment 2017, 13:1627-1632
Published Date: 21 June 2017
Pivotal response treatment for autism spectrum disorder: current perspectives
Lei J, Ventola P
Neuropsychiatric Disease and Treatment 2017, 13:1613-1626
Published Date: 20 June 2017
Effects of subthalamic nucleus deep brain stimulation on emotional working memory capacity and mood in patients with Parkinson's disease
Merkl A, Röck E, Schmitz-Hübsch T, Schneider G, Kühn AA
Neuropsychiatric Disease and Treatment 2017, 13:1603-1611
Published Date: 19 June 2017
Stress reactivity and emotion in premenstrual syndrome
Liu Q, Wang Y, van Heck CH, Qiao W
Neuropsychiatric Disease and Treatment 2017, 13:1597-1602
Published Date: 16 June 2017
Clinical features of limbic encephalitis with LGI1 antibody
Wang ML, Cao XY, Liu QX, Ma W, Guo XQ, Liu XW
Neuropsychiatric Disease and Treatment 2017, 13:1589-1596
Published Date: 16 June 2017
Suicide and Lyme and associated diseases
Bransfield RC
Neuropsychiatric Disease and Treatment 2017, 13:1575-1587
Published Date: 16 June 2017
Prognostic value of restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis
Li J, Zhang T, Shao Q
Neuropsychiatric Disease and Treatment 2017, 13:1569-1574
Published Date: 16 June 2017
Risk factors for the existence of attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders
Lamanna AL, Craig F, Matera E, Simone M, Buttiglione M, Margari L
Neuropsychiatric Disease and Treatment 2017, 13:1559-1567
Published Date: 15 June 2017
De Ritis ratio (AST/ALT) as an independent predictor of poor outcome in patients with acute ischemic stroke
Gao F, Chen C, Lu J, Zheng J, Ma XC, Yuan XY, Huo K, Han JF
Neuropsychiatric Disease and Treatment 2017, 13:1551-1557
Published Date: 15 June 2017
Intelligence profiles of Chinese school-aged boys with high-functioning ASD and ADHD
Li G, Jiang W, Du Y, Rossbach K
Neuropsychiatric Disease and Treatment 2017, 13:1541-1549
Published Date: 15 June 2017
Burnout and compassion fatigue: prevalence and associations among Israeli burn clinicians
Haik J, Brown S, Liran A, Visentin D, Sokolov A, Zilinsky I, Kornhaber R
Neuropsychiatric Disease and Treatment 2017, 13:1533-1540
Published Date: 15 June 2017
Relapse and hospitalization in patients with schizophrenia and bipolar disorder at the St Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia: a comparative quantitative cross-sectional study
Ayano G, Duko B
Neuropsychiatric Disease and Treatment 2017, 13:1527-1531
Published Date: 15 June 2017
Pituitary abscess: report of two cases and review of the literature
Liu Y, Liu F, Liang Q, Li Y, Wang ZF
Neuropsychiatric Disease and Treatment 2017, 13:1521-1526
Published Date: 13 June 2017
Cognitive dysfunction in major depression and Alzheimer's disease is associated with hippocampus–prefrontal cortex dysconnectivity
Sampath D, Sathyanesan M, Newton SS
Neuropsychiatric Disease and Treatment 2017, 13:1509-1519
Published Date: 12 June 2017
Effects of Canon chord progression on brain activity and motivation are dependent on subjective feelings, not the chord progression per se
Kayashima Y, Yamamuro K, Makinodan M, Nakanishi Y, Wanaka A, Kishimoto T
Neuropsychiatric Disease and Treatment 2017, 13:1499-1508
Published Date: 12 June 2017
The prevalence and risk factors of young male schizophrenics with non-alcoholic fatty liver disease
Yan J, Hou C, Liang Y
Neuropsychiatric Disease and Treatment 2017, 13:1493-1498
Published Date: 12 June 2017
Sleep apnea leading to Parkinson’s disease – an important association
Shafqat MN, Aadil M, Shoaib M
Neuropsychiatric Disease and Treatment 2017, 13:1491-1492
Published Date: 9 June 2017
PAC1 receptor (ADCYAP1R1) genotype and problematic alcohol use in a sample of young women
Dragan WŁ, Czerski PM, Dragan M
Neuropsychiatric Disease and Treatment 2017, 13:1483-1489
Published Date: 8 June 2017
Disrupted small-world brain functional network topology in male patients with severe obstructive sleep apnea revealed by resting-state fMRI
Chen L, Fan X, Li H, Nie S, Gong H, Zhang W, Zeng X, Long P, Peng D
Neuropsychiatric Disease and Treatment 2017, 13:1471-1482
Published Date: 8 June 2017
Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depression
Takahashi H, Higuchi H, Sato K, Kamata M, Yoshida K, Nishimura K
Neuropsychiatric Disease and Treatment 2017, 13:1463-1469
Published Date: 7 June 2017
Regional impairment of intrinsic functional connectivity strength in patients with chronic primary insomnia
Huang S, Zhou F, Jiang J, Huang M, Zeng X, Ding S, Gong H
Neuropsychiatric Disease and Treatment 2017, 13:1449-1462
Published Date: 6 June 2017
Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report
Terao T, Ishida A, Kimura T, Yoshida M, Hara T
Neuropsychiatric Disease and Treatment 2017, 13:1441-1448
Published Date: 6 June 2017
Ictal blinking, an under-recognized phenomenon: our experience and literature review
Saporito MAN, Vitaliti G, Pavone P, Di Stefano G, Striano P, Caraballo RH, Falsaperla R
Neuropsychiatric Disease and Treatment 2017, 13:1435-1439
Published Date: 31 May 2017
Effects of stimulus parameters on motor seizure duration in electroconvulsive therapy
Joo SW, Joo YH, Kim CY, Lee JS
Neuropsychiatric Disease and Treatment 2017, 13:1427-1434
Published Date: 29 May 2017
Development of a Body Image Concern Scale using both exploratory and confirmatory factor analyses in Chinese university students
He W, Zheng Q, Ji Y, Shen C, Zhu Q, Wang W
Neuropsychiatric Disease and Treatment 2017, 13:1419-1425
Published Date: 29 May 2017
Primary angle-closure glaucomas disturb regional spontaneous brain activity in the visual pathway: an fMRI study
Chen W, Zhang L, Xu YG, Zhu K, Luo M
Neuropsychiatric Disease and Treatment 2017, 13:1409-1417
Published Date: 25 May 2017
The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study
Rosic T, Naji L, Bawor M, Dennis BB, Plater C, Marsh DC, Thabane L, Samaan Z
Neuropsychiatric Disease and Treatment 2017, 13:1399-1408
Published Date: 24 May 2017
Topiramate add-on treatment associated with normalization of prolactin levels in a patient with schizophrenia
Huang Y, Ma H, Wang Y, Peng M, Zhu G
Neuropsychiatric Disease and Treatment 2017, 13:1395-1397
Published Date: 24 May 2017
Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia
Aksay SS, Bumb JM, Remennik D, Thiel M, Kranaster L, Sartorius A, Janke C
Neuropsychiatric Disease and Treatment 2017, 13:1389-1394
Published Date: 23 May 2017
Hirayama disease (monomelic amyotrophy) clinically confused for carpal tunnel syndrome
Ay H
Neuropsychiatric Disease and Treatment 2017, 13:1385-1388
Published Date: 22 May 2017
Developmental and behavioral outcomes of uncomplicated monochorionic diamniotic twins born in the third trimester
Sierakowski A, Eapen V, Črnčec R, Smoleniec J
Neuropsychiatric Disease and Treatment 2017, 13:1373-1384
Published Date: 19 May 2017
Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report
Matsui K, Takaesu Y, Inoue T, Inada K, Nishimura K
Neuropsychiatric Disease and Treatment 2017, 13:1367-1371
Published Date: 19 May 2017
Understanding the associations between psychosocial factors and severity of crime in juvenile delinquency: a cross-sectional study
Taşkıran S, Mutluer T, Tufan AE, Semerci B
Neuropsychiatric Disease and Treatment 2017, 13:1359-1366
Published Date: 18 May 2017
Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US survey
Gross HJ, Watson C
Neuropsychiatric Disease and Treatment 2017, 13:1349-1357
Published Date: 18 May 2017
Productivity and deadweight losses due to relapses of schizophrenia in Japan
Nakamura Y, Mahlich J
Neuropsychiatric Disease and Treatment 2017, 13:1341-1348
Published Date: 17 May 2017
Potential role of pre- and postnatal testosterone levels in attention-deficit/hyperactivity disorder: is there a sex difference?
Wang LJ, Chou MC, Chou WJ, Lee MJ, Lee SY, Lin PY, Lee YH, Yang YH, Yen CF
Neuropsychiatric Disease and Treatment 2017, 13:1331-1339
Published Date: 16 May 2017
Psychosis in parkinsonism: an unorthodox approach
Onofrj M, Carrozzino D, D'Amico A, Di Giacomo R, Delli Pizzi S, Thomas A, Onofrj V, Taylor JP, Bonanni L
Neuropsychiatric Disease and Treatment 2017, 13:1313-1330
Published Date: 16 May 2017
Robot-assisted gait training for stroke patients: current state of the art and perspectives of robotics
Morone G, Paolucci S, Cherubini A, De Angelis D, Venturiero V, Coiro P, Iosa M
Neuropsychiatric Disease and Treatment 2017, 13:1303-1311
Published Date: 15 May 2017
Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
Kishi T, Ikuta T, Matsunaga S, Matsuda Y, Oya K, Iwata N
Neuropsychiatric Disease and Treatment 2017, 13:1281-1302
Published Date: 11 May 2017
ESSENCE-Q – used as a screening tool for neurodevelopmental problems in public health checkups for young children in south Japan
Hatakenaka Y, Ninomiya H, Billstedt E, Fernell E, Gillberg C
Neuropsychiatric Disease and Treatment 2017, 13:1271-1280
Published Date: 10 May 2017
Novel urinary metabolite signature for diagnosing postpartum depression
Lin L, Chen X, Liu R
Neuropsychiatric Disease and Treatment 2017, 13:1263-1270
Published Date: 10 May 2017
Biomarkers for depression: recent insights, current challenges and future prospects
Strawbridge R, Young AH, Cleare AJ
Neuropsychiatric Disease and Treatment 2017, 13:1245-1262
Published Date: 10 May 2017
Factor structure, reliability, and validity of the Japanese version of the Hoarding Rating Scale-Self-Report (HRS-SR-J)
Tsuchiyagaito A, Horiuchi S, Igarashi T, Kawanori Y, Hirano Y, Yabe H, Nakagawa A
Neuropsychiatric Disease and Treatment 2017, 13:1235-1243
Published Date: 9 May 2017
Stigma associated with mental illness: perspectives of university students in Qatar
Zolezzi M, Bensmail N, Zahrah F, Khaled SM, El-Gaili T
Neuropsychiatric Disease and Treatment 2017, 13:1221-1233
Published Date: 9 May 2017
New standardized nursing cooperation workflow to reduce stroke thrombolysis delays in patients with acute ischemic stroke
Zhou Y, Xu Z, Liao J, Feng F, Men L, Xu L, He Y, Li G
Neuropsychiatric Disease and Treatment 2017, 13:1215-1220
Published Date: 9 May 2017
Anorexia nervosa of the restrictive type and celiac disease in adolescence
Nacinovich R, Tremolizzo L, Corbetta F, Conti E, Neri F, Bomba M
Neuropsychiatric Disease and Treatment 2017, 13:1211-1214
Published Date: 4 May 2017
Connectivity to computers and the Internet among patients with schizophrenia spectrum disorders: a cross-sectional study
Välimäki M, Kuosmanen L, Hätönen H, Koivunen M, Pitkänen A, Athanasopoulou C, Anttila M
Neuropsychiatric Disease and Treatment 2017, 13:1201-1209
Published Date: 27 April 2017
Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients
Talih FR, Ajaltouni JJ, Tamim HM, Kobeissy FH
Neuropsychiatric Disease and Treatment 2017, 13:1193-1200
Published Date: 26 April 2017
Protective efficacy of a single salvianolic acid A treatment on photothrombosis-induced sustained spatial memory impairments
Jiao CX, Zhou H, Yang CX, Ma C, Yang YX, Mao RR, Xu L, Zhou QX
Neuropsychiatric Disease and Treatment 2017, 13:1181-1192
Published Date: 26 April 2017
The genetic relationship between epilepsy and hemiplegic migraine
Huang Y, Xiao H, Qin X, Nong Y, Zou D, Wu Y
Neuropsychiatric Disease and Treatment 2017, 13:1175-1179
Published Date: 24 April 2017
The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study
Liang Y, Yu X
Neuropsychiatric Disease and Treatment 2017, 13:1163-1173
Published Date: 21 April 2017
Trichotillomania: the impact of treatment history on the outcome of an Internet-based intervention
Weidt S, Bruhl AB, Delsignore A, Zai G, Kuenburg A, Klaghofer R, Rufer M
Neuropsychiatric Disease and Treatment 2017, 13:1153-1162
Published Date: 21 April 2017
Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE
Medvedev VE
Neuropsychiatric Disease and Treatment 2017, 13:1141-1151
Published Date: 21 April 2017
Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions
Ostendorf AP, Ng YT
Neuropsychiatric Disease and Treatment 2017, 13:1131-1140
Published Date: 20 April 2017
Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole
Salzman PM, Raoufinia A, Legacy S, Such P, Eramo A
Neuropsychiatric Disease and Treatment 2017, 13:1125-1129
Published Date: 20 April 2017
Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting
Nakagawa R, Ohnishi T, Kobayashi H, Yamaoka T, Yajima T, Tanimura A, Kato T, Yoshizawa K
Neuropsychiatric Disease and Treatment 2017, 13:1115-1124
Published Date: 19 April 2017
Perceived parental affectionless control is associated with high neuroticism
Takahashi N, Suzuki A, Matsumoto Y, Shirata T, Otani K
Neuropsychiatric Disease and Treatment 2017, 13:1111-1114
Published Date: 18 April 2017
Levodopa-responsive depression associated with corticobasal degeneration: a case report
Tarakita N, Nishijima H, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2017, 13:1107-1110
Published Date: 18 April 2017
Psychosis in behavioral variant frontotemporal dementia
Gossink FT, Vijverberg EGB, Krudop W, Scheltens P, Stek ML, Pijnenburg YAL, Dols A
Neuropsychiatric Disease and Treatment 2017, 13:1099-1106
Published Date: 13 April 2017
Treatment satisfaction with paliperidone extended-release tablets: open-label study in schizophrenia patients dissatisfied with previous antipsychotic medication
Yang FD, Li J, Tan YL, Liang WY, Zhang R, Wang N, Feng W, Cai S, Zhuo JM, Zhang LL
Neuropsychiatric Disease and Treatment 2017, 13:1089-1097
Published Date: 13 April 2017
Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia
Kadasah S, Arfin M, Rizvi S, Al-Asmari M, Al-Asmari A
Neuropsychiatric Disease and Treatment 2017, 13:1081-1088
Published Date: 12 April 2017
Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder?
Chan MH, Leung PW, Ho TP, Hung SF, Lee CC, Tang CP, Cheung KC, Ching FY, Chan FH, Chen LH, Garcia-Barcelo M, Sham PC
Neuropsychiatric Disease and Treatment 2017, 13:1071-1080
Published Date: 11 April 2017
Metabolic screening and its impact in children with non-syndromic intellectual disability
Ali YF, EL-Morshedy S, Elsayed RM, EL-sherbini AM, El-Sayed SAM, Abdrahman NIA, Imam AA
Neuropsychiatric Disease and Treatment 2017, 13:1065-1070
Published Date: 19 April 2017
Clinical and biochemical study of D-serine metabolism among schizophrenia patients
El-Tallawy HN, Saleem TH, El-Ebidi AMA, Hassan MH, Gabra RH, Farghaly WMA, Abo El-Maali N, Sherkawy HS
Neuropsychiatric Disease and Treatment 2017, 13:1057-1063
Published Date: 10 April 2017
Pathogenic beliefs among patients with depressive disorders
Neelapaijit A, Wongpakaran T, Wongpakaran N, Thongpibul K
Neuropsychiatric Disease and Treatment 2017, 13:1047-1055
Published Date: 10 April 2017
Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report
Horikoshi S, Miura I, Kunii Y, Asano S, Kanno-Nozaki K, Mashiko H, Yabe H
Neuropsychiatric Disease and Treatment 2017, 13:1043-1045
Published Date: 7 April 2017
An innovative nonpharmacological intervention combined with intravenous patient-controlled analgesia increased patient global improvement in pain and satisfaction after major surgery
Chuang CC, Lee CC, Wang LK, Lin BS, Wu WJ, Ho CH, Chen JY
Neuropsychiatric Disease and Treatment 2017, 13:1033-1042
Published Date: 6 April 2017
Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
Maneeton B, Putthisri S, Maneeton N, Woottiluk P, Suttajit S, Charnsil C, Srisurapanont M
Neuropsychiatric Disease and Treatment 2017, 13:1023-1032
Published Date: 4 April 2017
Recombinant human brain-derived neurotrophic factor prevents neuronal apoptosis in a novel in vitro model of subarachnoid hemorrhage
Li M, Wang Y, Wang W, Zou C, Wang X, Chen Q
Neuropsychiatric Disease and Treatment 2017, 13:1013-1021
Published Date: 3 April 2017
Relationship between hypnosis and personality trait in participants with high or low hypnotic susceptibility
Zhang Y, Wang Y, Shen C, Ye Y, Shen S, Zhang B, Wang J, Chen W, Wang W
Neuropsychiatric Disease and Treatment 2017, 13:1007-1012
Published Date: 3 April 2017
An Internet-based program for depressive symptoms using human and automated support: a randomized controlled trial
Mira A, Bretón-López J, García-Palacios A, Quero S, Baños RM, Botella C
Neuropsychiatric Disease and Treatment 2017, 13:987-1006
Published Date: 31 March 2017
Punding following posterior cerebral artery infarction: a case report and review of literature
Lin CI, Lin YC, Lien WC, Hsieh PC, Lin SH, Kuan TS
Neuropsychiatric Disease and Treatment 2017, 13:981-985
Published Date: 31 March 2017
Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)
Vasilescu AN, Schweinfurth N, Borgwardt S, Gass P, Lang UE, Inta D, Eckart S
Neuropsychiatric Disease and Treatment 2017, 13:973-980
Published Date: 31 March 2017
Twelve-week physical exercise does not have a long-lasting effect on kynurenines in plasma of depressed patients
Millischer V, Erhardt S, Ekblom Ö, Forsell Y, Lavebratt C
Neuropsychiatric Disease and Treatment 2017, 13:967-972
Published Date: 31 March 2017
Sleep apnea and the subsequent risk of Parkinson’s disease: a 3-year nationwide population-based study
Chou PS, Lai CL, Chou YH, Chang WP
Neuropsychiatric Disease and Treatment 2017, 13:959-965
Published Date: 30 March 2017
Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
Fridman M, Banaschewski T, Sikirica V, Quintero J, Chen KS
Neuropsychiatric Disease and Treatment 2017, 13:947-958
Published Date: 30 March 2017
Comparing the ability of cognitive and affective Theory of Mind in adolescent onset schizophrenia
Li D, Li X, Yu F, Chen X, Zhang L, Li D, Wei Q, Zhang Q, Zhu C, Wang K
Neuropsychiatric Disease and Treatment 2017, 13:937-945
Published Date: 27 March 2017
Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes
Wang M, Zhang Y, Feng L, Zheng J, Fan S, Liu J, Yang N, Liu Y, Zuo P
Neuropsychiatric Disease and Treatment 2017, 13:927-935
Published Date: 27 March 2017
The Maugeri Stress Index – reduced form: a questionnaire for job stress assessment
Massidda D, Giorgi I, Vidotto G, Tringali S, Imbriani M, Baiardi P, Bertolotti G
Neuropsychiatric Disease and Treatment 2017, 13:917-926
Published Date: 24 March 2017
Illness denial questionnaire for patients and caregivers
Rossi Ferrario S, Giorgi I, Baiardi P, Giuntoli L, Balestroni G, Cerutti P, Manera M, Gabanelli P, Solara V, Fornara R, Luisetti M, Omarini P, Omarini G, Vidotto G
Neuropsychiatric Disease and Treatment 2017, 13:909-916
Published Date: 23 March 2017
Association study of MIF promoter polymorphisms with suicide completers in the Japanese population
Shimmyo N, Hishimoto A, Otsuka I, Okazaki S, Boku S, Mouri K, Horai T, Takahashi M, Ueno Y, Shirakawa O, Sora I
Neuropsychiatric Disease and Treatment 2017, 13:899-908
Published Date: 22 March 2017
Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms
Kasper S, Dienel A
Neuropsychiatric Disease and Treatment 2017, 13:889-898
Published Date: 22 March 2017
The influence of depression, level of functioning in everyday life, and illness acceptance on quality of life in patients with Parkinson's disease: a preliminary study
Rosińczuk J, Kołtuniuk A
Neuropsychiatric Disease and Treatment 2017, 13:881-887
Published Date: 21 March 2017
Dynamic balance in children with attention-deficit hyperactivity disorder and its relationship with cognitive functions and cerebellum
Goetz M, Schwabova JP, Hlavka Z, Ptacek R, Surman CBH
Neuropsychiatric Disease and Treatment 2017, 13:873-880
Published Date: 21 March 2017
Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion
Katahira H, Sunagawa M, Watanabe D, Kanada Y, Katayama A, Yamauchi R, Takashima M, Ishikawa S, Hisamitsu T
Neuropsychiatric Disease and Treatment 2017, 13:863-872
Published Date: 20 March 2017
Type D personality as a predictor of self-efficacy and social support in patients with type 2 diabetes mellitus
Shao Y, Yin H, Wan C
Neuropsychiatric Disease and Treatment 2017, 13:855-861
Published Date: 20 March 2017
Long-term efficacy and safety of lamotrigine for all types of bipolar disorder
Watanabe Y, Hongo S
Neuropsychiatric Disease and Treatment 2017, 13:843-854
Published Date: 20 March 2017
Rapamycin modulated brain-derived neurotrophic factor and B-cell lymphoma 2 to mitigate autism spectrum disorder in rats
Zhang J, Liu LM, Ni J
Neuropsychiatric Disease and Treatment 2017, 13:835-842
Published Date: 20 March 2017
Some children with autism have latent social skills that can be tested
Hrdlicka M, Urbanek T, Vacova M, Beranova S, Dudova I
Neuropsychiatric Disease and Treatment 2017, 13:827-833
Published Date: 16 March 2017
Neuropsychiatric symptoms in untreated Parkinson’s disease
Szatmari S, Illigens BM, Siepmann T, Pinter A, Takats A, Bereczki D
Neuropsychiatric Disease and Treatment 2017, 13:815-826
Published Date: 16 March 2017
Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
Jha MK, Teer RB, Minhajuddin A, Greer TL, Rush AJ, Trivedi MH
Neuropsychiatric Disease and Treatment 2017, 13:803-813
Published Date: 15 March 2017
Validation and cultural adaptation of the Arabic versions of the Mini–Mental Status Examination – 2 and Mini-Cog test
Albanna M, Yehya A, Khairi A, Dafeeah E, Elhadi A, Rezgui L, Al Kahlout S, Yousif A, Uthman B, Al-Amin H
Neuropsychiatric Disease and Treatment 2017, 13:793-801
Published Date: 14 March 2017
Attention-deficit hyperactivity disorder in elementary school students in Shantou, China: prevalence, subtypes, and influencing factors
Huang Y, Zheng S, Xu C, Lin K, Wu K, Zheng M, Zhang J, Xu H
Neuropsychiatric Disease and Treatment 2017, 13:785-792
Published Date: 14 March 2017
Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan
Sugawara N, Danjo K, Furukori H, Sato Y, Tomita T, Fujii A, Nakagami T, Kitaoka K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2017, 13:779-784
Published Date: 13 March 2017
Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report
Narita Z, Takano H, Sumiyoshi T
Neuropsychiatric Disease and Treatment 2017, 13:775-777
Published Date: 13 March 2017
Preliminary evaluation of a “formulation-driven cognitive behavioral guided self-help (fCBT-GSH)” for crisis and transitional case management clients
Naeem F, Johal RK, Mckenna C, Calancie O, Munshi T, Hassan T, Nasar A, Ayub M
Neuropsychiatric Disease and Treatment 2017, 13:769-774
Published Date: 10 March 2017
Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults [Corrigendum]
Nakato Y, Inoue T, Nakagawa S, Kitaichi Y, Kameyama R, Wakatsuki Y, Kitagawa K, Omiya Y, Kusumi I
Neuropsychiatric Disease and Treatment 2017, 13:767-768
Published Date: 9 March 2017
Lithium in late-life mania: a systematic review
De Fazio P, Gaetano R, Caroleo M, Pavia M, De Sarro G, Fagiolini A, Segura-Garcia C
Neuropsychiatric Disease and Treatment 2017, 13:755-766
Published Date: 9 March 2017
A Chinese version of the Psychotic Symptom Rating Scales: psychometric properties in recent-onset and chronic psychosis
Chien WT, Lee IY, Wang LQ
Neuropsychiatric Disease and Treatment 2017, 13:745-753
Published Date: 8 March 2017
Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin
Combs BL, Cox AG
Neuropsychiatric Disease and Treatment 2017, 13:737-744
Published Date: 8 March 2017
Bipolar disorder recurrence prevention using self-monitoring daily mood charts: case reports from a 5 year period
Yasui-Furukori N, Nakamura K
Neuropsychiatric Disease and Treatment 2017, 13:733-736
Published Date: 7 March 2017
The role of deep brain stimulation in Parkinson’s disease: an overview and update on new developments
Fang JY, Tolleson C
Neuropsychiatric Disease and Treatment 2017, 13:723-732
Published Date: 7 March 2017
Monitoring brain multiparameters and hypothermia in severe traumatic brain injury
Vasconcelos FR, Andrade AF, Teixeira MJ, Paiva WS
Neuropsychiatric Disease and Treatment 2017, 13:721-722
Published Date: 8 March 2017
Prevalence of dementia in Egypt: a systematic review
Elshahidi MH, Elhadidi MA, Sharaqi AA, Mostafa A, Elzhery MA
Neuropsychiatric Disease and Treatment 2017, 13:715-720
Published Date: 6 March 2017
New opinion on the subtypes of poststroke depression in Chinese stroke survivors
Yue Y, Liu R, Cao Y, Wu Y, Zhang S, Li H, Zhu J, Jiang W, Wu A, Yuan Y
Neuropsychiatric Disease and Treatment 2017, 13:707-713
Published Date: 6 March 2017
Influence of CFH gene on symptom severity of schizophrenia
Zhang C, Lv QY, Fan WX, Tang W, Yi ZH
Neuropsychiatric Disease and Treatment 2017, 13:697-706
Published Date: 2 March 2017
Efficacy and safety of oxcarbazepine in the treatment of children with epilepsy: a meta-analysis of randomized controlled trials
Geng H, Wang CZ
Neuropsychiatric Disease and Treatment 2017, 13:685-695
Published Date: 2 March 2017
Effects of a structured 20-session slow-cortical-potential-based neurofeedback program on attentional performance in children and adolescents with attention-deficit hyperactivity disorder: retrospective analysis of an open-label pilot-approach and 6-month follow-up
Albrecht JS, Bubenzer-Busch S, Gallien A, Knospe EL, Gaber TJ, Zepf FD
Neuropsychiatric Disease and Treatment 2017, 13:667-683
Published Date: 2 March 2017
Risk of recurrent overdose associated with prescribing patterns of psychotropic medications after nonfatal overdose
Okumura Y, Nishi D
Neuropsychiatric Disease and Treatment 2017, 13:653-665
Published Date: 2 March 2017
Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan
Cheng YS, Shyu YC, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Wang LJ
Neuropsychiatric Disease and Treatment 2017, 13:643-651
Published Date: 1 March 2017
Screening for bipolar disorder among migraineurs: the impact of migraine–bipolar disorder comorbidity on disease characteristics
Kivilcim Y, Altintas M, Domac FM, Erzincan E, Gülec H
Neuropsychiatric Disease and Treatment 2017, 13:631-641
Published Date: 1 March 2017
Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study
Horsdal HT, Benros ME, Köhler-Forsberg O, Krogh J, Gasse C
Neuropsychiatric Disease and Treatment 2017, 13:621-630
Published Date: 28 February 2017
Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
Luan S, Wan H, Wang S, Li H, Zhang B
Neuropsychiatric Disease and Treatment 2017, 13:609-620
Published Date: 27 February 2017
Quality of life in children and adolescents with obsessive–compulsive disorder: a systematic review and meta-analysis
Coluccia A, Ferretti F, Fagiolini A, Pozza A
Neuropsychiatric Disease and Treatment 2017, 13:597-608
Published Date: 24 February 2017
Contemplating stem cell therapy for epilepsy-induced neuropsychiatric symptoms
Rao G, Mashkouri S, Aum D, Marcet P, Borlongan CV
Neuropsychiatric Disease and Treatment 2017, 13:585-596
Published Date: 23 February 2017
Prefrontal cortex activation during neuropsychological tasks might predict response to pharmacotherapy in patients with obsessive–compulsive disorder
Takeda T, Sumitani S, Hamatani S, Yokose Y, Shikata M, Ohmori T
Neuropsychiatric Disease and Treatment 2017, 13:577-583
Published Date: 23 February 2017
Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study
Vrbova K, Prasko J, Ociskova M, Kamaradova D, Marackova M, Holubova M, Grambal A, Slepecky M, Latalova K
Neuropsychiatric Disease and Treatment 2017, 13:567-576
Published Date: 23 February 2017
Gender differences in the association between HTR2C gene variants and suicidal behavior in a Mexican population: a case–control study
Molina-Guzman G, González-Castro TB, Hernández-Díaz Y, Tovilla-Zárate CA, Juárez-Rojop IE, Guzmán-Priego CG, Genis A, Pool García S, López-Narvaez ML, Rodriguez-Perez JM
Neuropsychiatric Disease and Treatment 2017, 13:559-566
Published Date: 22 February 2017
Assessment of poststroke mania and diagnosis
Shoaib M, Aadil M
Neuropsychiatric Disease and Treatment 2017, 13:557-558
Published Date: 21 February 2017
Validation of the Revised Illness Perception Questionnaire in Turkish epilepsy patients and the effects of earthquake experience on perception of disease
Keskin Güler S, Güler S, Gökçe Çokal B, Gunes N, Yon Mİ, Yoldas TK
Neuropsychiatric Disease and Treatment 2017, 13:551-556
Published Date: 21 February 2017
Analysis concerning nutritional behaviors in the context of the risk of orthorexia
Olejniczak D, Bugajec D, Panczyk M, Brytek-Matera A, Religioni U, Czerw A, Grąbczewska A, Juszczyk G, Jabłkowska-Górecka K, Staniszewska A
Neuropsychiatric Disease and Treatment 2017, 13:543-550
Published Date: 21 February 2017
Gene expression-based biological test for major depressive disorder: an advanced study
Watanabe S, Numata S, Iga J, Kinoshita M, Umehara H, Ishii K, Ohmori T
Neuropsychiatric Disease and Treatment 2017, 13:535-541
Published Date: 21 February 2017
Association of carotid atherosclerosis and recurrent cerebral infarction in the Chinese population: a meta-analysis
Liu J, Zhu Y, Wu Y, Liu Y, Teng Z, Hao Y
Neuropsychiatric Disease and Treatment 2017, 13:527-533
Published Date: 20 February 2017
Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
Jiang KD, Li LJ, Wang XY, Fang MS, Shi JF, Cao QY, He JC, Wang JN, Tan WH, Hu CL
Neuropsychiatric Disease and Treatment 2017, 13:515-526
Published Date: 17 February 2017
Abnormal resting-state brain activities in patients with first-episode obsessive-compulsive disorder
Niu Q, Yang L, Song X, Chu C, Liu H, Zhang L, Li Y, Zhang X, Cheng J, Li Y
Neuropsychiatric Disease and Treatment 2017, 13:507-513
Published Date: 16 February 2017
Blood pressure and anthropometry in children treated with stimulants: a longitudinal cohort study with an individual approach
Landgren M, Nasic S, Johnson M, Lövoll T, Holmgren D, Fernell E
Neuropsychiatric Disease and Treatment 2017, 13:499-506
Published Date: 16 February 2017
From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution
Cheng YW, Chen TF, Chiu MJ
Neuropsychiatric Disease and Treatment 2017, 13:491-498
Published Date: 16 February 2017
Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial
Demarin V, Bašić Kes V, Trkanjec Z, Budišić M, Bošnjak Pašić M, Črnac P, Budinčević H
Neuropsychiatric Disease and Treatment 2017, 13:483-490
Published Date: 16 February 2017
Associations among depressive symptoms, childhood abuse, neuroticism, and adult stressful life events in the general adult population
Ono K, Takaesu Y, Nakai Y, Shimura A, Ono Y, Murakoshi A, Matsumoto Y, Tanabe H, Kusumi I, Inoue T
Neuropsychiatric Disease and Treatment 2017, 13:477-482
Published Date: 15 February 2017
Abnormalities of localized connectivity in schizophrenia patients and their unaffected relatives: a meta-analysis of resting-state functional magnetic resonance imaging studies
Xiao B, Wang S, Liu J, Meng T, He Y, Luo X
Neuropsychiatric Disease and Treatment 2017, 13:467-475
Published Date: 14 February 2017
Delirium after a traumatic brain injury: predictors and symptom patterns
Maneewong J, Maneeton B, Maneeton N, Vaniyapong T, Traisathit P, Sricharoen N, Srisurapanont M
Neuropsychiatric Disease and Treatment 2017, 13:459-465
Published Date: 14 February 2017
Global economic burden of schizophrenia: response to authors’ reply
Neil AL, Carr VJ
Neuropsychiatric Disease and Treatment 2017, 13:457-458
Published Date: 14 February 2017
Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control
Fridman M, Banaschewski T, Sikirica V, Quintero J, Erder MH, Chen KS
Neuropsychiatric Disease and Treatment 2017, 13:443-455
Published Date: 13 February 2017
Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
Yoshimura R, Katsuki A, Atake K, Hori H, Igata R, Konishi Y
Neuropsychiatric Disease and Treatment 2017, 13:437-441
Published Date: 14 February 2017
Abnormal whole-brain functional connectivity in patients with primary insomnia
Li C, Dong M, Yin Y, Hua K, Fu S, Jiang G
Neuropsychiatric Disease and Treatment 2017, 13:427-435
Published Date: 13 February 2017
Repetitive hyperbaric oxygen treatment increases insulin sensitivity in diabetes patients with acute intracerebral hemorrhage
Xu Q, Wei Y, Fan S, Wang L, Zhou XP
Neuropsychiatric Disease and Treatment 2017, 13:421-426
Published Date: 10 February 2017
The dynamic relationship between emotional and physical states: an observational study of personal health records
Lee YS, Jung WM, Jang H, Kim S, Chung SY, Chae Y
Neuropsychiatric Disease and Treatment 2017, 13:411-419
Published Date: 9 February 2017
Diagnostic challenges leading to underdiagnosis of dissociative disorders
Aadil M, Shoaib M
Neuropsychiatric Disease and Treatment 2017, 13:407-410
Published Date: 8 February 2017
Resting-state functional connectivity changes within the default mode network and the salience network after antipsychotic treatment in early-phase schizophrenia
Wang Y, Tang W, Fan X, Zhang J, Geng D, Jiang K, Zhu D, Song Z, Xiao Z, Liu D
Neuropsychiatric Disease and Treatment 2017, 13:397-406
Published Date: 7 February 2017
Risk assessment of aggressive behavior in Chinese patients with schizophrenia by fMRI and COMT gene
Tang X, Jin J, Tang Y, Cao J, Huang J
Neuropsychiatric Disease and Treatment 2017, 13:387-395
Published Date: 7 February 2017
Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe
Fridman M, Banaschewski T, Sikirica V, Quintero J, Erder MH, Chen KS
Neuropsychiatric Disease and Treatment 2017, 13:373-386
Published Date: 7 February 2017
A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
Clemow DB, Bushe C, Mancini M, Ossipov MH, Upadhyaya H
Neuropsychiatric Disease and Treatment 2017, 13:357-371
Published Date: 3 February 2017
Use of transcranial direct current stimulation for the treatment of auditory hallucinations of schizophrenia – a systematic review
Pondé PH, de Sena EP, Camprodon JA, Araújo AN, Neto MF, DiBiasi M, Baptista AF, Moura LMVR, Cosmo C
Neuropsychiatric Disease and Treatment 2017, 13:347-355
Published Date: 1 February 2017
N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: case reports and methods for detection
Tsutsui K, Kanbayashi T, Takaki M, Omori Y, Imai Y, Nishino S, Tanaka K, Shimizu T
Neuropsychiatric Disease and Treatment 2017, 13:339-345
Published Date: 8 February 2017
Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females
Farhadi F, Vosoughi K, Shahidi GA, Delbari A, Lökk J, Fereshtehnejad SM
Neuropsychiatric Disease and Treatment 2017, 13:329-338
Published Date: 1 February 2017
The parental bonding in families of adolescents with anorexia: attachment representations between parents and offspring
Balottin L, Mannarini S, Rossi M, Rossi G, Balottin U
Neuropsychiatric Disease and Treatment 2017, 13:319-327
Published Date: 1 February 2017
The spectrum of psychosis in multiple sclerosis: a clinical case series
Gilberthorpe TG, O'Connell KE, Carolan A, Silber E, Brex PA, Sibtain NA, David AS
Neuropsychiatric Disease and Treatment 2017, 13:303-318
Published Date: 1 February 2017
A fully integrated new paradigm for lithium’s mode of action – lithium utilizes latent cellular fail-safe mechanisms
van Woerkom AE
Neuropsychiatric Disease and Treatment 2017, 13:275-302
Published Date: 31 January 2017
The relationship between childhood trauma and adult psychosis in a UK Early Intervention Service: results of a retrospective case note study
Reeder FD, Hussain N, Rhouma A, Haddad PM, Munshi T, Naeem F, Khachatryan D, Chaudhry IB
Neuropsychiatric Disease and Treatment 2017, 13:269-273
Published Date: 8 February 2017
Role of prediabetes in stroke
Mijajlović MD, Aleksić VM, Šternić NM, Mirković MM, Bornstein NM
Neuropsychiatric Disease and Treatment 2017, 13:259-267
Published Date: 2 February 2017
Visual–spatial training efficacy in children affected by migraine without aura: a multicenter study
Precenzano F, Ruberto M, Parisi L, Salerno M, Maltese A, Gallai B, Marotta R, Lavano SM, Lavano F, Roccella M
Neuropsychiatric Disease and Treatment 2017, 13:253-258
Published Date: 27 January 2017
Efficacy of a short cognitive training program in patients with multiple sclerosis
Pérez-Martín MY, González-Platas M, Eguía-del Rio P, Croissier-Elías C, Jiménez Sosa A
Neuropsychiatric Disease and Treatment 2017, 13:245-252
Published Date: 3 February 2017
A survey of eMedia-delivered interventions for schizophrenia used in randomized controlled trials
Naeem F, Munshi T, Xiang S, Yang M, Shokraneh F, Syed Y, Ayub M, Adams CE, Farooq S
Neuropsychiatric Disease and Treatment 2017, 13:233-243
Published Date: 27 January 2017
Assessment and monitoring of treatment response in adult ADHD patients: current perspectives
Ramsay JR
Neuropsychiatric Disease and Treatment 2017, 13:221-232
Published Date: 27 January 2017
Minimal invasive puncture and drainage versus endoscopic surgery for spontaneous intracerebral hemorrhage in basal ganglia
Li Z, Li Y, Xu F, Zhang X, Tian Q, Li L
Neuropsychiatric Disease and Treatment 2017, 13:213-219
Published Date: 25 January 2017
Construct validity of the Depression and Somatic Symptoms Scale: evaluation by Mokken scale analysis
Chou YH, Lee CP, Liu CY, Hung CI
Neuropsychiatric Disease and Treatment 2017, 13:205-211
Published Date: 23 January 2017
Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study
Ifteni P, Teodorescu A, Moga MA, Pascu AM, Miclaus RS
Neuropsychiatric Disease and Treatment 2017, 13:201-204
Published Date: 23 January 2017
A possible role of the Infant/Toddler Sensory Profile in screening for autism: a proof-of-concept study in the specific sample of prematurely born children with birth weights <1,500 g
Beranova S, Stoklasa J, Dudova I, Markova D, Kasparova M, Zemankova J, Urbanek T, Talasek T, Luukka P, Hrdlicka M
Neuropsychiatric Disease and Treatment 2017, 13:191-200
Published Date: 23 January 2017
A preliminary study of Patient Dignity Inventory validation among patients hospitalized in an acute psychiatric ward
Di Lorenzo R, Cabri G, Carretti E, Galli G, Giambalvo N, Rioli G, Saraceni S, Spiga G, Del Giovane C, Ferri P
Neuropsychiatric Disease and Treatment 2017, 13:177-190
Published Date: 23 January 2017
Neuroleptic malignant syndrome: an easily overlooked neurologic emergency
Oruch R, Pryme IF, Engelsen BA, Lund A
Neuropsychiatric Disease and Treatment 2017, 13:161-175
Published Date: 16 January 2017
Evaluation of the risk factors of depressive disorders comorbid with obstructive sleep apnea
Cai LQ, Xu LY, Wei LL, Sun Y, Chen W
Neuropsychiatric Disease and Treatment 2017, 13:155-159
Published Date: 16 January 2017
Factor structure of the Persian version of general, social, and negative self-consciousness of appearance domains of Derriford Appearance Scale 59: an application in the field of burn injuries
Sadeghi-Bazargani H, Zare Z, Ranjbar F
Neuropsychiatric Disease and Treatment 2017, 13:147-154
Published Date: 16 January 2017
Effects of paliperidone extended release on hostility among Thai patients with schizophrenia
Jariyavilas A, Thavichachart N, Kongsakon R, Chantakarn S, Arunpongpaisal S, Chantarasak V, Jaroensook P, Kittiwattanagul K, Nerapusee O
Neuropsychiatric Disease and Treatment 2017, 13:141-146
Published Date: 12 January 2017
Association of peripheral neuropathy with sleep-related breathing disorders in myotonic dystrophies
Banach M, Antczak J, Rola R
Neuropsychiatric Disease and Treatment 2017, 13:133-140
Published Date: 12 January 2017
Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study
Kongsaengdao S, Maneeton B, Maneeton N
Neuropsychiatric Disease and Treatment 2017, 13:127-132
Published Date: 10 January 2017
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N
Neuropsychiatric Disease and Treatment 2017, 13:117-125
Published Date: 6 January 2017
Cognitive profiles in bilingual children born to immigrant parents and Italian monolingual native children with specific learning disorders
Riva A, Nacinovich R, Bertuletti N, Montrasi V, Marchetti S, Neri F, Bomba M
Neuropsychiatric Disease and Treatment 2017, 13:109-116
Published Date: 30 December 2016
Risperidone improves interpersonal perception and executive function in patients with schizophrenia
Zhou Z, Zhu Y, Wang J, Zhu H
Neuropsychiatric Disease and Treatment 2017, 13:101-107
Published Date: 28 December 2016
Long-term bicycle riding ameliorates the depression of the patients undergoing hemodialysis by affecting the levels of interleukin-6 and interleukin-18
Zhao C, Ma H, Yang L, Xiao Y
Neuropsychiatric Disease and Treatment 2017, 13:91-100
Published Date: 28 December 2016
Aripiprazole augmentation in managing comorbid obsessive–compulsive disorder and bipolar disorder: a case with suicidal attempts
Lai J, Lu Q, Zhang P, Xu T, Xu Y, Hu S
Neuropsychiatric Disease and Treatment 2017, 13:87-90
Published Date: 28 December 2016
The role of heme oxygenase-1 (HO-1) in the regulation of inflammatory reaction, neuronal cell proliferation and apoptosis in rats after intracerebral hemorrhage (ICH)
Fan XZ, Mu LS
Neuropsychiatric Disease and Treatment 2017, 13:77-85
Published Date: 28 December 2016
Alterations of white matter fractional anisotropy in unmedicated obsessive–compulsive disorder
Tao J, Wang XL, Zhong ZY, Han HY, Liu S, Wen SL, Guan NH, Li LJ
Neuropsychiatric Disease and Treatment 2017, 13:69-76
Published Date: 28 December 2016
Apathy and intrinsic functional connectivity networks in amnestic mild cognitive impairment
Joo SH, Lee CU, Lim HK
Neuropsychiatric Disease and Treatment 2017, 13:61-67
Published Date: 23 December 2016
A biopsychological review of gambling disorder
Quintero GC
Neuropsychiatric Disease and Treatment 2017, 13:51-60
Published Date: 23 December 2016
Local mild hypothermia therapy as an augmentation strategy for minimally invasive surgery of hypertensive intracerebral hemorrhage: a meta-analysis of randomized clinical trials
Han Y, Sheng K, Su M, Yang N, Wan D
Neuropsychiatric Disease and Treatment 2017, 13:41-49
Published Date: 23 December 2016
Atypical major depressive episode as initial presentation of intracranial germinoma in a male adolescent
Chen YT, Su KP, Chang JP
Neuropsychiatric Disease and Treatment 2017, 13:35-40
Published Date: 21 December 2016
Detailed course of depressive symptoms and risk for developing depression in late adolescents with subthreshold depression: a cohort study
Jinnin R, Okamoto Y, Takagaki K, Nishiyama Y, Yamamura T, Okamoto Y, Miyake Y, Takebayashi Y, Tanaka K, Sugiura Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S
Neuropsychiatric Disease and Treatment 2017, 13:25-33
Published Date: 22 December 2016
Temperament, personality, and treatment outcome in major depression: a 6-month preliminary prospective study
Kudo Y, Nakagawa A, Wake T, Ishikawa N, Kurata C, Nakahara M, Nojima T, Mimura M
Neuropsychiatric Disease and Treatment 2017, 13:17-24
Published Date: 19 December 2016
Pioglitazone could induce remission in major depression: a meta-analysis
Colle R, de Larminat D, Rotenberg S, Hozer F, Hardy P, Verstuyft C, Fève B, Corruble E
Neuropsychiatric Disease and Treatment 2017, 13:9-16
Published Date: 19 December 2016
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
Husain MI, Chaudhry IB, Hamirani MM, Minhas FA, Kazmi A, Hodsoll J, Haddad PM, Deakin JFW, Husain N, Young AH
Neuropsychiatric Disease and Treatment 2017, 13:1-8
Published Date: 19 December 2016